(insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL
There are no studies that show the safety and efficacy of Xultophy® 100/3.6 used after expiration or when stored outside of the recommended conditions. As such, Novo Nordisk cannot guarantee the potency of Xultophy® 100/3.6 when stored outside of the recommended storage conditions.1
Recommended Storage Conditions for Xultophy® 100/3.61
Before First Use
After First Use
Refrigerated (36°F - 46°F)
(59°F - 86°F)
(36°F - 46°F)
Until expiration date
See what to do when products are exposed to freezing or other conditions.
1. Xultophy® 100/3.6 Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.